GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Granules India Ltd (NSE:GRANULES) » Definitions » Loans Receivable

Granules India (NSE:GRANULES) Loans Receivable : ₹0 Mil (As of Dec. 2023)


View and export this data going back to 2005. Start your Free Trial

What is Granules India Loans Receivable?

Granules India's Loans Receivable for the quarter that ended in Dec. 2023 was ₹0 Mil.


Granules India Loans Receivable Historical Data

The historical data trend for Granules India's Loans Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Granules India Loans Receivable Chart

Granules India Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Loans Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Granules India Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Loans Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Granules India Loans Receivable Calculation

Loans Receivable are the funds that a company has lent but have not yet been repaid.


Granules India Loans Receivable Related Terms

Thank you for viewing the detailed overview of Granules India's Loans Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Granules India (NSE:GRANULES) Business Description

Traded in Other Exchanges
Address
3rd Block, My Home Hub, 2nd Floor, Madhapur, Hyderabad, TG, IND, 500 081
Granules India Ltd is an India-based pharmaceutical company. The company manufactures active pharmaceutical ingredients, pharmaceutical formulation intermediates and finished dosages. Its business is organized into three areas; the Core business which comprises core molecules such as Paracetamol, Ibuprofen, Metformin, Guaifenesin, and Methocarbamol; the Emerging business that focuses on manufacturing APIs and the US Generics. It has one segment Pharmaceutical products including ingredients and intermediaries. Its primary geographic markets are North America, Latin America, Europe, India, and Rest of World.

Granules India (NSE:GRANULES) Headlines

No Headlines